Patents

US 10383875 B2: Pharmaceutical formulations of xanthine or xanthine derivatives, and their use

Granted
2019-08-20
Filed
2017-06-12 application 15620430
Type
Utility · 23 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention relates to pharmaceutical formulations comprising xanthine or xanthine derivatives, kits thereof, and methods for treating fibrotic diseases by local administration.

Source: PVGPATDIS, file of 2026-04-10 (ipg190820.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
HARROW IP, LLC 15 patentsUS company or organizationSan Diego, CAPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Matthew J. BudererOak Harbor, OH3PVGPATDIS, file of 2026-04-10
Dennis Elias SaadehSan Diego, CA15PVGPATDIS, file of 2026-04-10
Andrew R. BollSan Diego, CA1PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/522PVGPATDIS, file of 2026-04-10
C12YEnzymesC12Y304/24PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2025-09-26Security interest Security interest
Security interest
HARROW, INC. signed 2025-09-26
HARROW IP, LLC signed 2025-09-26
FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT ROSEMONT, IL72384/781PASDL, file of 2026-10-15
2025-09-18Release of security interest
Release of security interest
OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT signed 2025-09-12HARROW IP, LLC NASHVILLE, TN72299/911PASDL, file of 2026-10-15
2023-03-30Security interest Security interest
Patent security agreement
HARROW IP, LLC signed 2023-03-27OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT LOS ANGELES, CA63205/708PASDL, file of 2026-10-15
2019-06-07Assignment
Assignment of assignor's interest
ETON PHARMACEUTICALS, INC. signed 2019-06-06HARROW IP, LLC SAN DIEGO, CA49402/589ECORSEXC, file of 2026-09-25
2017-07-27Assignment
Assignment of assignor's interest
BOLL, ANDREW R. signed 2017-06-29
SAADEH, DENNIS signed 2017-07-03
BUDERER, MATTHEW J. signed 2017-07-12
IMPRIMIS PHARMACEUTICALS, INC. SAN DIEGO, CA43121/11ECORSEXC, file of 2026-09-25
2017-07-27Assignment
Assignment of assignor's interest
IMPRIMIS PHARMACEUTICALS, INC. signed 2017-07-10ETON PHARMACEUTICALS, INC. DEER PARK, IL43120/957ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.